Published on 9 Oct 2023 on Zacks via Yahoo Finance

Are Medical Stocks Lagging Cabaletta Bio (CABA) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Cabaletta Bio, Inc. (CABA) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Cabaletta Bio, Inc. is one of 1094 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Cabaletta Bio, Inc. is currently sporting a Zacks Rank of #2 (Buy).